Darrin Miles
Amministratore Delegato presso Nested Therapeutics, Inc.
Profilo
Darrin Miles is currently the Chief Executive Officer & Director at Nested Therapeutics, Inc. Prior to this, he worked as the Chief Commercial Officer at Agios Pharmaceuticals, Inc. from 2015 to 2021.
He completed his undergraduate degree at Cornell University.
Posizioni attive di Darrin Miles
| Società | Posizione | Inizio |
|---|---|---|
Nested Therapeutics, Inc.
 Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nested Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company focuses on discovering and developing novel, targeted, small molecule precision medicine therapies for cancer patients. The company uses mutation clusters to identify druggable pockets and have a platform that utilizes insights from genomics, computational chemistry, proteomics, and AI. Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations to reach a broader group of patients. The company was founded by Arvin Dar and Klaus Hoeflich. The CEO is Darrin Miles. | Amministratore Delegato | - |
Precedenti posizioni note di Darrin Miles
| Società | Posizione | Fine |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 06/12/2021 |
Formazione di Darrin Miles
| Cornell University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Nested Therapeutics, Inc.
Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nested Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company focuses on discovering and developing novel, targeted, small molecule precision medicine therapies for cancer patients. The company uses mutation clusters to identify druggable pockets and have a platform that utilizes insights from genomics, computational chemistry, proteomics, and AI. Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations to reach a broader group of patients. The company was founded by Arvin Dar and Klaus Hoeflich. The CEO is Darrin Miles. | Commercial Services |
- Borsa valori
- Insiders
- Darrin Miles
